Study Protocol for an Open-Label, Single-Arm, Multicentre Phase II Trial to Evaluate the Efficacy and Safety of Combined Triplet Therapy and Olanzapine for Prevention of Carboplatin-Induced Nausea and Vomiting in Gynaecological Cancer Patients

BMJ Open - United Kingdom
doi 10.1136/bmjopen-2018-024357

Related search